Gastrointestinal OTC Drugs Market Size, Share, Growth and Industry Report

<p>The global gastrointestinal OTC drugs market size reached US$ 42.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 60.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4% during 2024-2032. The rising prevalence of gastrointestinal disorders, increasing awareness among the masses regarding digestive health, and the recent development of advanced formulations represent some of the key factors driving the market.</p>

<table align="center" border="1" cellpadding="1" cellspacing="1" dir="ltr" style="width:100%">
<thead>
<tr>
<th scope="col" style="width:70%">
<div style="text-align:left"><strong>Report Attribute</strong></div>
</th>
<th scope="col">
<div style="text-align:left">Key Statistics</div>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>
<div><strong>Base Year</strong></div>
</td>
<td>2023</td>
</tr>
<tr>
<td>
<div><strong>Forecast Years</strong></div>
</td>
<td>
<div>2024-2032</div>
</td>
</tr>
<tr>
<td>
<div><strong>Historical Years</strong></div>
</td>
<td>
<div>2018-2023</div>
</td>
</tr>
<tr>
<td><strong>Market&nbsp;Size in 2023</strong></td>
<td>US$ 42.0 Billion</td>
</tr>
<tr>
<td><strong>Market Forecast in 2032</strong></td>
<td>US$ 60.5 Billion</td>
</tr>
<tr>
<td><strong>Market&nbsp;Growth Rate (2024-2032)</strong></td>
<td>4%</td>
</tr>
</tbody>
</table>

<p>IMARC Group provides an analysis of the key trends in each segment of the global gastrointestinal OTC drugs market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on drug class, indication, and end user.</p>

全球胃肠非处方药物市场规模于2023年达到420亿美元。展望未来，IMARC集团预计该市场将在2032年增至605亿美元，预计在2024-2032年期间将以4%的复合年增长率（CAGR）增长。胃肠疾病发病率的上升、公众对消化健康认识的增强以及先进配方的发展是推动市场增长的关键因素之一。